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Abstract
Background: HIV is treated as a chronic disease, but high lost-to-follow-up rates and poor adherence to
medication result in higher mortality, morbidity, and viral mutation. Within 18 clinical sites in rural Zambézia
Province, Mozambique, patient adherence to antiretroviral therapy has been sub-optimal.
Methods: To better understand barriers to adherence, we conducted 18 community and clinic focus groups in six
rural districts. We interviewed 76 women and 88 men, of whom 124 were community participants (CP; 60 women,
64 men) and 40 were health care workers (HCW; 16 women, 24 men) who provide care for those living with HIV.
Results: While there was some consensus, both CP and HCW provided complementary insights. CP focus groups
noted a lack of confidentiality and poor treatment by hospital staff (42% CP vs. 0% HCW), doubt as to the benefits
of antiretroviral therapy (75% CP vs. 0% HCW), and sharing medications with family members (66% CP vs. 0%HCW).
Men expressed a greater concern about poor treatment by HCW than women (83% men vs. 0% women). Health
care workers blamed patient preference for traditional medicine (42% CP vs. 100% HCW) and the side effects of
medication for poor adherence (8% CP vs. 83% CHW).
Conclusions: Perspectives of CP and HCW likely reflect differing sociocultural and educational backgrounds. Health
care workers must understand community perspectives on causes of suboptimal adherence as a first step toward
effective intervention.
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Background
Mozambique has one of the highest HIV infection rates in
sub-Saharan Africa, with a national prevalence estimated
between 11.5% and 16% [1-4]. Funding from international
donors has allowed the Ministry of Health (MISAU) to
expand HIV care and treatment services to rural commu-
nities [3-7], but only 24% of eligible patients in 2009 were
accessing combination antiretroviral therapy (cART) [8].
Access to care and treatment is poorer in rural areas than
in urban areas where, historically, educational and health
care services were better established [1,9-12]. With fund-
ing from the U.S. President’s Emergency Plan for AIDS
Relief (PEPFAR), Friends in Global Health (FGH), which is
affiliated with the Vanderbilt Institute for Global Health
(VIGH), has partnered with MISAU to provide support
for HIV care and treatment in clinics throughout Zambé-
zia Province (Figure 1). Zambézia had an adult prevalence
of 12.6% [4] in 2009. For cART to be effective, patients
must adhere to their treatment regimens [13,14]. Poor
adherence can lead to the emergence of drug resistance
and eventually loss of immune function resulting in
disease progression [15]. In rural Zambézia, the lost-to-fol-
low-up rate among HIV-positive patients was ≈50% in
2008 (TDM, unpublished data).
Qualitative and quantitative studies have identified
barriers to adherence, including: medication side effects,
complexity of dosing schedules, low patient education
levels, low socioeconomic status, stigma, transportation
unavailability or cost, simply forgetting, and time away
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improve adherence in rural areas has been well docu-
mented in Haiti and Uganda [5,8,14,18], but only one
study has been conducted in rural Mozambique [8]. In
some studies, adherence rates in Africa have been docu-
mented to equal or exceed those in Western countries
[19], while other studies have raised concern with cur-
rent adherence rates and the measurement tools
employed [20]. Explanations for high rates of adherence
include use of social networks of HIV positive patients
to encourage all members to take medications [21,22],
non-adherent patients were excluded from treatment
given limited availability [23], or that some cART pro-
grams provided effective, but unsustainable services and
incentives for patients [24]. Currently, all HIV-positive
patients in Zambézia Province receive free health care
services, but nutritional supplements, transportation
assistance, and financial incentives are rarely available.
The rural location of our clinical sites, coupled with
comparatively low levels of adherence, suggested the
need to learn more about perceived barriers to patient
adherence within our clinical setting.
Methods
This study was carried out in six rural districts (Gilé, Ile,
Namacurra, Inhassunge, Alto Molócuè, and Lugela) in
Zambézia Province, Mozambique (Figure 2). The study
was evaluated and approved by the Mozambican National
Bioethics Committee and the Vanderbilt Institutional
Review Board. We conducted three focus groups in each
district to achieve saturation: one with women from the
community, one with men from the community, and one
with health care workers (HCW) who treat people living
with HIV. Potential participants from the community
were invited by a community leader to share their experi-
ences and perceptions related to HIV and ART medication
adherence, regardless of the given HIV serostatus of the
participant. We requested the community leader obtain a
reasonably diverse sample of the community by selecting
participants from different families, neighborhoods, ages,
and occupations. The community leader created a list of
30 people complete with basic demographic information
for our team to review. Focus group leaders chose the
final participants based on achieving a range of ages,
families, and professions. Only one person per family was
allowed to participate. All of those who were approached
to participate agreed; all provided written consent.
Community focus groups were conducted with same sex
participants in each of the six districts. Community parti-
cipants were asked “Why might people with HIV not take
their medications every day, as instructed?” and “Why
might people not seek or continue treatment for HIV?”
We asked participants to respond to these questions only
if they knew someone close with them who had been
using ART of if they themselves were on medication. We
believe this was useful as participants could respond about
specific issues without having to claim the experience as
their own. While the last question requested information
about seeking and continuing treatment for HIV, only
responses related to continuation of HIV treatment were
analyzed and included in this manuscript.
In addition to community groups, focus groups of 5 to
11 health care workers (mixed gendered) were conducted
in each of the 6 districts. Health care worker participants
were asked “What do you think are the biggest barriers
to ART adherence for your patients?” Health care work-
ers were encouraged to talk about both formal medical
adherence (how many pills taken per day) and about why
patients may stop taking their medication all together.
We recognize that the questions for community and
HCW were not exactly the same, but as education levels
Figure 1 Map of Southern Africa, highlighting Mozambique.
Figure 2 Map of Zambézia Province, Mozambique.
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q u e s t i o n sw o u l dg e ta tt h ei m p o r t a n tq u e s t i o no fw h y
people did not always take medicine or would interrupt
their HIV care.
The focus groups were conducted by trained moderators
(all had previous experience conducting multiple focus
groups in Mozambique) who spoke Portuguese, Chuabo
and Lowme. All community focus groups were conducted
in the preferred local language. Participants were asked a
variety of questions regarding perceptions of HIV illness
as well as perceived barriers to ART adherence. Sessions
were audio taped and translated/transcribed into Portu-
guese and English. Transcriptions were reviewed by three
members of the team to ensure that the spirit of the
responses was preserved in the translation. Data were ana-
lyzed using content analysis in which no preconceived
categories were established and researchers independently
created categories as they coded the data into important
themes. Data were coded by hand, without using a compu-
ter program. Two authors (KG and CA) coded the data
separately and compared results; only a single interpretive
category discrepancy was discovered. This was discussed
and was reconciled by collapsing two data categories into
one.
Results
Characteristics of participants
Of the 76 women and 88 men who participated in our
focus groups, 124 were volunteers from the community
(60 women, 64 men) and 40 were health care workers (16
women, 24 men). No one refused to participate in the
focus groups. Community participants had a mean age of
35 years, had low levels of education (mean of 4 years),
and primarily worked as subsistence farmers (73%). Health
care workers were younger than the community group
(mean of 30 years) and were better educated (average of
11 years; most with a post secondary degree); 55% were in
health care services (pharmacist, laboratory technician,
medical technician, information technician, nurse) and
45% were in social services (social assistant, peer educator,
counselor).
Economic Barriers to Adherence
Economic obstacles to ART adherence were noted by all
groups and included financial barriers to procuring food
and transportation. Identified by 14 of 18 (78%) focus
groups, the inability to afford quality or sufficient food
was widely reported as a barrier to ART adherence.
Patients who begin ART regimens often experience an
increased appetite, resulting in “unrelenting hunger” [25],
which in turn lead to anxiety about lack of food, a factor
in subsequent non-adherence, in the view of the focus
group members. A man in the district of Alto Molócuè
said, “The problem here has to do with economic
conditions. The problem with food is huge. It’s not possi-
ble to eat caracata [boiled flour meal] with dry salty fish.
Problems with illness are aggravated because of the lack
of food.” One HCW agreed, stating, “Nutrition is compli-
cated. When projects that give food to people on ART
stop, the people stop returning.”
Noted by 12 of 18 groups (67%), inadequate transporta-
tion was an important barrier to cART adherence. Some
participants may have the financial means, but are
impeded by the poor quality of roads and unreliability of
public transportation. A man from the district of Lugela
noted that, “Others don’t get treated due to a lack of trans-
p o r t a t i o n .T h o s ew h ol i v ef a ra w a yh a v ed i f f i c u l t ya c c e s -
sing treatment. The roads and bridges aren’t good.” A
HCW from Alto Molócuè agreed, “Our geographic distri-
bution is a factor. People who live far away abandon treat-
ment.” As cART patients in Mozambique are required to
return to the clinic each month to receive their medica-
tions, it was noted that this might create a significant
strain on the financial resources of some patients.
Patient-Provider Challenges
In addition to economic barriers, poor relationships and
conflicts with health worker staff may also deter patient
adherence. Men in particular focused on the lack of
confidentiality and poor treatment by hospital staff. A
man from Ile said,
They should put a doctor here because the people
here don’t work at all. The other day a woman died
there in the hospital because they didn’t treat her.
People prefer to die with traditional medicine
because the hospital doesn’t treat them
Another added,
If [a patient] asks [a pharmacist] to repeat what they
said because [the patient] didn’tu n d e r s t a n d ,[ t h e
pharmacist] is insulted. [The pharmacist will] say,
‘sir, you should study at a school.’ And they say this
i nt h ep r e s e n c eo fm a n yw o m e n .T h ew o m e ns i t
there and laugh.”
The clinical sites at all of these locations are small,
and confidentiality is difficult to maintain. In some
clinics, there are particular offices used only for the test-
ing and treatment of HIV-positive patients, creating
inadvertent patient disclosure. Pharmacy windows are
crowded. The likelihood of a patient receiving confiden-
tial service in this context is very limited.
HCW also note the challenges of creating good relation-
ships and communicating information about HIV to their
patients. Health care workers suggest language barriers
and problems with patients being overwhelmed with
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don’t understand what we say, but always respond affirma-
tively by nodding their heads.” In large part, language is
the barrier to effective communication. This was noted by
many in the community, including a man from Nama-
curra who said,
They explain things in Portuguese in the hospital. The
only things we know how to say are head and belly [in
Portuguese]. Sometimes when we have chest pain, we
say we have belly pain because we don’t know how to
say “chest.” When we have ear pain, we say “head”
because we don’t know how to say “ear” and the nurse
gives us a prescription that functions for my
complaint.
The language barrier creates a challenge in ensuring
that patients truly understand the importance of ART
adherence or how to take their medication properly. A
doctor from Gile explained,
The counselor has to do a study of the person, if we
can or can’t talk about the subject, or postpone it. We
shouldn’t fill the person with information because they
aren’t going to understand everything we tell them.
Health care workers implicated ART side effects as
being one of the most important barriers to adherence,
but this was not echoed by community participants (8%
of community focus groups vs. 83% of health care
worker focus groups). A HCW in Namacurra gave an
example of how side effects have affected patients:
There have been 2 or 3 cases of people whose skin
looked burned ... These patients have a tendency to
tell us that the medicines that the hospital gives are
not good. We need to re-explain that side effects are
possible and it’s important not to abandon treatment.
Men living in Alto Molócuè, the only larger town in the
study, were the only community focus group to present
this as a barrier. One man said,
The nurses don’t inform [patients] of the types of
reactions they might have. When the medical techni-
cian gives the prescription and afterward explains
what the side effects are, the sick person won’ts t o p
taking the medicine. I don’tk n o wi ft h e r ei sap e r -
son here who has ever been told of side effects.
Social Barriers to Adherence
Four barriers to adherence that exist outside of the clin-
ical arena were noted by focus group participants. These
included the practice of saving medication, the belief
that medication should be curative, the use of traditional
healers, and the existence of stigma surrounding HIV
infection. The first three are cultural practices that pre-
cede the coming of the HIV epidemic, while the forth
(stigma) is linked specifically to HIV infection and AIDS
but is exacerbated by accepted gender norms and
expectations.
Eight of 12 (66%) community groups referred to the
practice of saving medicine to give to others. One
woman from Ile stated, “When we receive 4 pills and
our children are sick, too, we divide them: 2 for me and
2 for them. You see this often in our community.” Pills
are also shared between other family members and
friends, creating a perceived social network of support.
Others save their medication for their own use at a later
time, in case the illness recurs. A man in the district of
Lugela explains,
You can go to the hospital and buy your medicine
and return to your house and begin to take it. Two
days later you feel well and because you know you
don’t have more money, you stop taking it so that
when you’re sick the next time, you can take the
same medication even though you don’tk n o wi fi t
will cure you or make you worse.
Many people in the community believed that if a med-
icine is good, it should be curative. None of the health
care worker focus groups voiced concern about the
effectiveness of ART, but 9o f1 2( 7 5 % )c o m m u n i t y
focus groups believed this to be a barrier. The concept
of chronic diseases that require a lifetime of treatment
is a relatively new idea in rural Mozambique, and not
well understood or widely accepted. “People have the
idea that medicines cure in the first 3 days,” said a man
from Alto Molócuè, “I’ll take the medicine today,
tomorrow, and the day after, and if I’mn o tc u r e d ,I
have to abandon treatment to find other medicines.”
Another woman in Gile noted,
“People don’t go to the hospital because they know
that they won’t be cured, but are only given informa-
tion cards ... I [may] go to the hospital feeling well
but leave ill. But why, since I was feeling well?
Therefore, it’s preferable to stay home, with or with-
out AIDS.”
The juxtaposition of having an illness even if a person
has no symptoms has no correlate in local understand-
ing of disease, given that there is no tradition of chronic
disease control and management (e.g., for hypertension
or rheumatoid arthritis), making chronic cART for HIV
a difficult concept for many to understand.
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patients’ preferences for traditional healers were a barrier
to ART adherence, whereas all 6 (100%) of the health care
provider focus groups cited this to be a barrier. A health
care worker from Namacurra said,
There are many cases when patients prefer traditional
treatments [to their ART]... Much later, the patient
stops that treatment and returns to the health center,
but many times they are already in the final phases
and they come to die here.”
A community member from Namacurra expressed one
reason why medication is sought from a traditional healer,
First we go to the hospital, and if we’re not cured,
we go to the traditional healer to try because some-
times traditional medicine is very strong and good
because it hasn’t been modified chemically.
Participants suggested patients’ often preferred to seek
care with a traditional healer because of the respect
given to patient’s concerns and their ability to effectively
communicate with the healer in their native language.
The impact of stigma on adherence for many illnesses
is well documented in the literature [26-29]. Noted in
14 of 18 (78%) groups, stigma directed toward those
infected and the resulting fear of disclosure felt by those
who test positive has a negative impact on adherence to
ART. This was a particular challenge for men and
women in sexual relationships. A medical technician in
the district of Gilé stated,
Well known people abandon treatment because they
don’tw a n ta n y o n et ok n o wt h e ya r eH I V - p o s i t i v e .
This is a big problem because I see them dating peo-
ple I know, who were not HIV-positive, but now are.
Both men and women have the additional challenge of
engaging in sexual relationships while maintaining their
health and that of their partners. A HCW in Inhassunge
noted, “Women are afraid to tell their husbands. When
they have to hide their illness in order to avoid divorce,
they often abandon treatment.” The fear of losing a part-
ner was so strong that often people would risk their own
health to avoid disclosure. For women, disclosing their
health status could lead to divorce, which could result in
the loss of their children and their financial stability, as
men could force them to leave the family home.
Discussion
Barriers to adherence perceived by focus groups, both
community participants and health care workers,
included: the inability to afford food in sufficient quantity
or quality, a lack of transportation availability, and
stigma/shame. These barriers have been cited in studies
in other low income countries and may be especially
acute in a rural, impoverished setting [10,16,25,30,31].
Several factors perceived as barriers by community parti-
cipants appeared less important to health care workers
and vice versa. While our study was not designed to com-
pare these two groups with statistical rigor, the differ-
ences in their perspectives provide insight into potential
interventions that may bolster adherence. Several inter-
ventions can be developed on the basis of information
gathered during our study.
1. Provide food supplementation to patients enrolled in
care. The issue of food insecurity is particularly challen-
ging in Zambézia, as the province has high background
rates of moderate and severe malnutrition among young
children [32]. In 2008, 46% of children in Zambézia Pro-
vince suffered from moderate or severe malnutrition,
suggesting that even when illness is not a factor, acquir-
ing adequate and nutritious food in the province is a
challenge [33]. Our PEPFAR program in Zambézia does
not routinely provide nutritional supplements to HIV
positive patients (as per PEPFAR and MISAU guidance),
but clinicians and community members agree that add-
ing food supplement programs would be a means of
improving patient adherence to medication.
2. Improve patient/provider relationships. Community
participants complained about the lack of confidentiality
and poor treatment by hospital staff. Men appear to be
particularly sensitive to degrading comments or treatment
by HCW. Studies from Tanzania, Zimbabwe, and South
Africa have documented poor relationships between clini-
cians and patients have negative impact on drug adher-
ence [34-36]. Creating effective communicating between
patients and clinicians, who are from very different social
and/or ethnic background is challenging [37]. Cultural
training and solid communication skills are necessary [38].
To improve service quality, we have begun training in
effective communication skills and have created screened
areas around pharmacy counters to provide more privacy
for patients.
3. Integrate traditional healers and religious healers into
the medical system. The treatment activities of traditional
practitioners have come under scrutiny in recent years
[39-47]. Our previous study conducted in Zambézia sug-
gested that a majority of the population has sought care
from a healer, but often seeks care from a clinical site first
[48]. Participants who spoke about traditional healers as
barriers to clinical care primarily shifted the “blame” of
their using traditional medicine onto clinical workers who
were ineffectual. Many state that they only seek care from
a healer if they were told nothing could be done for them
at the clinic. Use of complementary and alternative medi-
cines has been found to delay patient initiation of ART in
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association of alternative medicine use with poor ART
adherence [50]. In Zambézia, we have begun training tra-
ditional healers about HIV diagnosis, treatment and co-
infections, and we have established a system of patient
referrals. We are hopeful that better coordination with tra-
ditional healers may forge a therapeutic alliance for better
overall HIV care, but we do not yet know if this will be
achievable
4. Engage ‘expert’ patients to mentor those initiating
ART. Culturally specific understanding of illness and
treatment may be more effectively addressed by someone
who shares the same background. Given the historical
absence of any chronic disease management infrastruc-
ture in rural Mozambique, we were not surprised that
the expressed belief that “good” medicine will “cure
within a few days” w a sc o m m o nw i t h i no u rc o m m u n i t y
focus groups. This view of illness as acute and transient
has been shown to contribute to poor adherence in other
communities [28].
In addition to traditional understanding of effective
treatment, the sharing of ARVs was cited by community
participants as a barrier to adherence. This phenomenon
has been documented elsewhere [51-53]. Patients may
have resorted to sharing medication during “stock-outs”
that have occurred, especially early in ART roll-out. How-
ever, we hypothesize, based on comments from partici-
pants, that sharing medication may be more strongly
related to the establishment of social networks among
community members. With high levels of poverty in the
province, sharing medicine of any sort may provide a
social safety net for rural poor, as many medications are
costly. While ART is provided free of charge, the travel
cost and time associated with traveling to clinical sites
may induce some to borrow medication from friends or
family members. Given the prevalent view that illnesses
have a spiritual origin, rather than an infectious one, we
speculate that rigid adherence is a goal of health care
workers more often than patients [48]. To counter these
beliefs we believe expert patients, can effectively teach new
patients skills to successfully adhere to their medication as
has been found in Mexico [54].
We believe our study provides new insights into ART
adherence that can inform programmatic changes within
rural Mozambique. The strengths of our study are the
broader insights provided by the complementary focus
groups, both in the community and among HCW. Con-
ducting focus groups with men, women and HCW in each
community allowed us to effectively reach a diverse group
of participants. A limitation of our findings is that focus
groups are known to elicit more views of verbal partici-
pants than shy ones. While we attempted to sample for
diversity, our participants were not selected randomly and
were chosen by community leaders. As HIV status was
not a factor in participation, it is likely that many were not
HIV positive. Some participant’ss p o k eo ft h e i ro w n
experiences with HIV, while others recounted stories
experienced by their family and friends. In addition, trans-
lation from local languages to Portuguese (and subse-
quently to English) further complicates analysis. The
challenge of cultural understanding can be difficult in
rural areas where only local languages are understood,
though research leadership from a medical anthropologist
(CMA) was useful. While we have made all attempts to
maintain the integrity of our data, it is possible that some
words or phrases were incorrectly translated, though we
believe the substantive viewpoints were correctly inferred.
Conclusion
Focus group discussions highlighted differing percep-
tions of barriers to adherence among community parti-
cipants and health care workers. Economic and logistical
barriers, including a lack of food and transportation,
were almost universally noted by both groups. Cultural
barriers were also noted, including health care worker
rudeness and disrespect, sharing of antiretroviral drugs
with family and friends, and the view of illness as acute
and transient. Hence, both structural changes to pro-
grams and culturally sensitive education efforts are
needed to improve adherence. Effective partnerships
with traditional healers would be beneficial given the
frequency with which their services are sought for HIV
and non-HIV related conditions alike [48,55]. Promoting
better dialogue between patients and providers can
probe patient fears and concerns and provide insight
into potential challenges to optimal patient adherence.
In the absence of resources necessary to provide trans-
portation and food subsidies to patients on ART or
employ armies of community health workers facilitating
directly observed ART administration, ART programs in
rural Africa face daunting challenges to ensure adequate
adherence.
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